Fed Announces $9 Billion Available for Hazardous PFAS Removal:

 

BioLargo (Maker of POOPH) Meets Challenging EPA Requirements and Has Major Advantages Over Competing Technologies

• PFAS is known as the contaminant of the century and is linked to cancer, endocrine disruption, liver damage, and more

• An investigation from non-profit ChemSec found that the global societal costs of PFAS chemicals, including remediation and health care, amount to $17 trillion/year

• The EPA recently passed challenging 4 parts per trillion restrictions on PFAS in drinking water

• EPA exercises enforcement provision of CERCLA to require polluters to pay for cleanup

• BioLargo’s AEC PFAS removal is proven to meet EPA new standard and has major advantages over competition

• The Fed announced spending $9 Billion for PFAS Removal that could increase with time because the need is so large and unmet

• Previous Senior Director and senior management of world’s largest seller of water in the world, Metropolitan Water District of Southern California recently joined BioLargo Board of Directors

• Previous Senior Advisor to EPA, Sally Guttierez joined BioLargo Board of Directors

• BioLargo is also commercializing several other highly disruptive products for healthcare, energy and air quality

• BioLargo shares trade close to 32 cents per share and support a market cap of only $100 million 

 

Most of us know very little about PFAS, but the recent actions by the EPA suggest that we should learn more because the EPA is restricting the amount of PFAS that can be in your drinking water to a maximum of only 4 parts per trillion.  The new standard of only 4 parts per trillion is partly explained by estimates of what PFAS is expected to cost in terms of healthcare and removal.

​

The Guardian published, “The societal cost of using toxic PFAS or “forever chemicals” across the global economy totals about $17.5T annually, a new analysis of the use of the dangerous compounds has found.  Meanwhile, the chemicals yield comparatively paltry profits for the world’s largest PFAS manufacturers – about $4bn annually.”  To get a better idea about PFAS and how this contaminant can impact you, watch this highly informative interview.

​

The EPA is giving water providers up to 5 years to meet the new requirements because it is a difficult challenge that will require a lot of time and money for a water provider to decide on the technology they want to use, and then to design, engineer and build the system.  It is significant to note that users will have to start spending substantial sums on the design and engineering early enough in the process to assure that they will be compliant on time.  They cannot risk the possibility of failing to comply with EPA requirements which could be lethal to providers that rely on steady water sales.  And failure to comply could be highly disruptive to end users who rely on a steady supply of clean water as a necessity of life.

​

Carbon Filtration is the leading technology employed today for PFAS removal, but BioLargo’s AEC has demonstrated significant cost and effectiveness advantages

Based on Green Planet Microcaps’ review of the claims of BioLargo’s AEC (Aqueous Electrostatic Collector), and on our review of competing technologies such as the predominantly employed granulated carbon filtration, it is our opinion that we believe no other technology that we have reviewed can compete with the BioLargo AEC PFAS removal system in terms of efficacy and in terms of cost.

In addition to efficiency and cost of operation, another factor for water providers to consider when deciding which system to adopt is, how much will it cost to dispose of any waste stream such as carbon filters that are packed with the PFAS that fall under this category?  A comparison between carbon filtration and the AEC claims that for every pound of carbon waste generated by BioLargo’s AEC, competing carbon filtration produces 42,000 pounds of carbon waste requiring disposal and destruction.  Green Planet Microcap reviewers believe the EPA will likely regulate the disposal of PFAS laden carbon filters when they are filled to capacity and clogged which could add 10 times the current cost of disposal of PFAS laden carbon filters.  The expected amount of PFAS laden carbon waste could be very large and very costly to dispose.

​

A water district in Stockholm, New Jersey is the first to order a system that is expected to be operational by Q4 this year and will serve as a model for all others to see.  With the new regulations firmly in place now and with the high capex and opex associated with PFAS removal systems, Green Planet Microcaps believes that BioLargo’s competitive edge is well positioned to gain a significant portion of the expected demand for the 148,000 public water suppliers in the United States.

​

In Addition to PFAS Removal, BioLargo is Commercializing Several Blockbuster Products Now

Over the past 10 years, BioLargo has been quietly inventing, proving, and partnering several life-changing products and is now commercializing them.

​

POOPH is the first product that is starting to go big.  POOPH is an amazing odor control product that really works, and it works without adding any additional fragrances to mask the unwanted odor.  POOPH breaks down the compounds that cause odors so they can't stink. Sales of POOPH have been growing 20% quarter over quarter consecutively for over 2 years and we believe this growth curve will continue for the long term.  Watch the attention-getting commercial and see for yourself.

​

Clyra, a subsidiary of BioLargo, is launching the world’s most powerful disinfectant that harms no cells.  It is FDA approved and it is likely to become the new gold standard in all surgeries, wound care, and dentistry related procedures.  This is close to a $10 billion market and growing fast.  The need is becoming more pressing because the current gold standard which is Betadine, has been recalled in some hospitals due to excessive toxicity problems.  The FDA found Clyra’s BioClynse to be safe and gentle yet highly effective as a disinfectant that even attacks biofilm.

​

BioLargo “Cellinity” Battery is major advancement in battery technology.  Management claims that they believe BioLargo’s liquid sodium sulfur battery is 2.5 times more energy dense than lithium ion and it does not catch fire or cause runaway fires.  Management further tells us that they believe their new battery will last for 20 years and that it uses no costly rare earths.  BioLargo is now just starting to produce the first prototype cells off their new production line that will be sent into the testing lab for certified specs. The potential for a battery with this description is quite large considering global demand is expected to increase from 185 GWh in 2020 to over 2000 GWh by 2030.

It is also worthy to note that BioLargo is creating a new concept for their Cellinity Battery that could be game-changing.  Instead of just making and selling batteries, BioLargo is creating a model where they license the technology to large users and assist them in the building of their own manufacturing plant.  This could expedite growth and cash flow by minimizing capital requirements and sharing in the ownership plus collecting an ongoing licensing fee.

​

The BioLargo story keeps growing every day.  Be sure to bookmark BioLargo and stay informed.

​

Conclusion

Investors have been accumulating BioLargo shares for the past few years and all indications from recent announcements suggest why shares have been rising and why they may continue to rise in the future.  Always do your own due diligence.  There is a treasure chest of information on the website and the market cap today is only about $100 million.  Inadequate cash and heavy losses are always major risks so it is important to know that BioLargo has no toxic debt, and a good cash position that is steadily improving.  BioLargo is very close to break even and could soon be experiencing positive cash flow. 

​

Legal Disclosures and Disclaimers

Green Planet Microcaps is not a registered investment adviser. The information that we provide from our website or newsletters is not, and should not be construed in any manner, to be investment advice. All opinions and information provided on this site are for educational and research purposes. Green Planet Microcaps encourages all readers to do their own due diligence and research when determining which investment strategies are best suited for them or to seek the advice of an investment professional.

​

Any information provided by Green Planet Microcaps should not be construed by any subscriber or prospective subscriber as a solicitation by Green Planet Microcaps to effect, or attempt to effect, any transaction in any security. Investments in the securities markets, and especially in private securities of small start-up companies, are incredibly and highly speculative and involve substantial risk that your entire investment could be lost. The information that we provide or that is derived from our website and/or newsletters should not be a substitute for advice from an investment professional. We encourage you to obtain personal advice from your professional investment advisor and to make independent investigations before acting on the information that you obtain from Green Planet Microcaps or derive from our website and/or newsletters. Only you can determine what level of risk is appropriate for you.

​

Specifically, we advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to purchase or trade in stocks or any securities presented on this website and/or in a particular newsletter. All information provided regarding the companies featured comes from the companies themselves, SEC filings, news releases, private placement memoranda, company websites as well as other sources of publicly available information. The profiles of these highlighted public and private companies are not in any way a solicitation or recommendation to buy, sell, or hold these or any other securities.

​

Most of the information on our website and/or newsletters or that we otherwise provide is derived directly from information published by the companies on which we report and/or from other sources we believe are reliable, without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. The information may contain discussions of, or provide access to, certain positions and recommendations as of a specific date. Due to various factors, including, but not limited to, changing market conditions, such discussions and positions/recommendations may no longer be reflective of current discussions and positions/recommendations. We do not in any way warrant or guarantee the success of nor endorse any action which you take in reliance on the information that we provide or that is derived from our website.

​

Investors should not rely solely on the information contained on this website or in any specific newsletter. Rather, investors should use the information contained on this Website and/or in newsletters as a starting point for doing additional independent research on the featured private and public companies. The advertisements within this newsletter are not to be construed as offers to purchase securities in the companies which may be the subject of such advertisements pursuant to federal or state law or the laws of any foreign jurisdiction.

Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects’”, “will,” “anticipates,” “estimates,” “believes,” “understands” or that by statements indicating certain actions “may,” “could,” or “might” occur. There is no guarantee past performance will be indicative of future results. The accuracy or completeness of the information in this newsletter is only as reliable as the sources they were obtained from.​ Green Planet Microcaps is compensated for investor relations services and will not be liable for any consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by Green Planet Microcaps or derived from Green Planet Microcap’s website and/or newsletters. Green Planet Microcaps shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber’s inability to use or any delay in accessing Green Planet Microcaps website or any other source of material provided by Green Planet Microcaps including newsletters; (3) any absence of material on Green Planet Microcaps; (4) Green Planet Microcaps failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. Green Planet Microcaps and each subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between Green Planet Microcaps and the subscriber.

​

Green Planet Microcaps is not affiliated with any brokerage firm and does not endorse or recommend any specific brokerage firm. Green Planet Microcaps is not and will not be responsible for any trades made by a broker on the subscriber’s behalf under any circumstances.

​